ResearcherNorthwell HealthActive in the last 2 years
Leila T. Tchelebi
Matched on ORCID iD 0000-0002-4789-449X; OpenAlex author ID A5067298210. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 38
2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 6
- NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy. Co-author DOI 10.1016/j.ijrobp.2024.10.026↗
- Adjuvant Radiation for Resected Pancreatic Cancer: Historical Review and Current State. Last author DOI 10.1016/j.semradonc.2025.07.009↗
- Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma: Systematic Revie… Co-author DOI 10.1097/coc.0000000000001076↗
- Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Large Diverse Health System Co-author DOI 10.1101/2023.09.19.23295749↗
- Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international syste… Co-author DOI 10.1002/cncr.32756↗
- Reducing the Toxicity of Radiotherapy for Pancreatic Cancer With Magnetic Resonance-guided Radiotherapy. Co-author DOI 10.1093/toxsci/kfaa021↗
Closest collaborators
The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Joseph M. Herman · 3 shared papers, 2023–2025 · strength 0.62
- Paper Adjuvant Radiation for Resected Pancreatic Cancer: Historical Review and Current State. DOI 10.1016/j.semradonc.2025.07.009↗
- Paper NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancre… DOI 10.1016/j.ijrobp.2024.10.026↗
- Paper Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Larg… DOI 10.1101/2023.09.19.23295749↗
- Karyn A. Goodman · 2 shared papers, 2025 · strength 0.47
- John Starner · 1 shared paper, 2025 · strength 0.28
- Ross Allen Abrams · 1 shared paper, 2025 · strength 0.28
- Nicholas George Zaorsky · 2 shared papers, 2020 · strength 0.25
- Theodore Sunki Hong · 1 shared paper, 2025 · strength 0.19
- Michael Frederick Bassetti · 1 shared paper, 2025 · strength 0.19
- Bradley A. Erickson · 1 shared paper, 2025 · strength 0.19
- William Adrian Hall · 1 shared paper, 2025 · strength 0.19
- Nina Niu Sanford · 1 shared paper, 2025 · strength 0.19
- Michael David Chuong · 1 shared paper, 2025 · strength 0.19
- Marsha Reyngold · 1 shared paper, 2025 · strength 0.19
- Todd Anthony Aguilera · 1 shared paper, 2025 · strength 0.19
- E.S. Paulson · 1 shared paper, 2025 · strength 0.19
- Eva Versteijne · 1 shared paper, 2025 · strength 0.19
- Hyun Jee Kim · 1 shared paper, 2025 · strength 0.19
- Richard Tuli · 1 shared paper, 2025 · strength 0.19
- Jennifer Yon-Li Wo · 1 shared paper, 2025 · strength 0.19
- Amol Kumar Narang · 1 shared paper, 2025 · strength 0.19
- Alice Chia-Chi Wei · 1 shared paper, 2025 · strength 0.19
- Christopher Leigh Hallemeier · 1 shared paper, 2024 · strength 0.18
- Suzanne M. Russo · 1 shared paper, 2024 · strength 0.18
- Rachit Kumar · 1 shared paper, 2024 · strength 0.18
- William C. Small · 1 shared paper, 2024 · strength 0.18
- Krishan R. Jethwa · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.